Clinical Trial Update: The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain [Phase 1]

View source ↗

Summary

A Phase 1 safety/efficacy study of iSCLife-LDP, a human umbilical cord mesenchymal stem cell therapy, for lumbar discogenic pain is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Discogenic Pain

Drugs mentioned

• iSCLife®-LDP

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Lumbar Discogenic Pain | Phase 1 | Status: RECRUITING